Skip to content

Effectiveness of VolleyVeilig: the prevention of injury among youth volleyball players

Effectiveness of VolleyVeilig: the prevention of injury among youth volleyball players

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
NL-OMON
Registry ID
NL-OMON20472
Enrollment
480
Registered
2019-04-08
Start date
2019-09-01
Completion date
Unknown
Last updated
2024-02-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Musculoskeletal injuries (acute and overuse injuries)

Interventions

The intervention ‘VolleyVeilig’ (available in Dutch) provides volleyball trainers/ coaches and players with a good and standard warming-up programme to prevent volleyball related injuries, and was spe

Sponsors

Department of Public and Occupational Health, Amsterdam UMC, locatie VUmc; Dutch Consumer Safety Institute VeiligheidNL; Nevobo, Dutch Volleyball Federation; Universitair Sportmedisch Centrum, University Medical Center Groningen; Dotcomsport
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Volleyball players aged 10 to 16 years, enrolled at one of the participating volleyball clubs and teams, who train under the guidance of a trainer/coach and participate in the Nevobo volleyball competition in the B- (14 to 16 years), C- (12 to 14 years) and D-youth category (10 to 12 years).

Exclusion criteria

Exclusion criteria: Teams are not eligible for study participation if the trainer/coach is not willing or able to register volleyball exposure and injuries weekly over one season for the players of his/her volleyball team.

Design outcomes

Primary

MeasureTime frame
Injury rate, severity of injuries and burden of injuries Compliance with intervention

Secondary

MeasureTime frame
Facilitators and barriers for the uptake of the VolleyVeilig youth programme in daily practice of Dutch volleyball clubs

Contacts

Public ContactEvert Verhagen

Department of Public and Occupational Health, Amsterdam UMC, locatie VUmc

e.verhagen@vumc.nl0204449691

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)